9th Circ. Upholds Ex-InterMune CEO's Fraud Conviction

Law360, New York (March 5, 2013, 5:16 PM EST) -- The former CEO of InterMune Inc. on Monday failed to persuade the Ninth Circuit to overturn his fraud conviction after the appeals court backed a jury's finding that his press release touting the drug Actimmune as a treatment for a deadly lung illness was intentionally misleading.

A three-judge panel found there was enough evidence that W. Scott Harkonen had falsely stated the results of a clinical trial in his August 2009 press release, affirming his September 2009 wire fraud conviction. The panel also said evidence sufficiently...
To view the full article, register now.